QUIA PHARMA AB (FRA:99B0) Gross Margin %: 0.00% (As of Jun. 2025)

What is QUIA PHARMA AB Gross Margin %?

QUIA PHARMA AB FRA:99B0 Gross Margin % is 0.00% as of Jun. 2025. The stock has 3 warning signs investors should review.

Gross Margin % is calculated as gross profit divided by its revenue. QUIA PHARMA AB's Gross Profit for the six months ended in Jun. 2025 was €-0.02 Mil. QUIA PHARMA AB's Revenue for the six months ended in Jun. 2025 was €0.00 Mil. Therefore, QUIA PHARMA AB's Gross Margin % for the quarter that ended in Jun. 2025 was 0.00%.

The historical rank and industry rank for QUIA PHARMA AB's Gross Margin % or its related term are showing as below:

During the past 13 years, the highest Gross Margin % of QUIA PHARMA AB was 57.34%. The lowest was -160.56%. And the median was 54.69%.

FRA:99B0's Gross Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: 60.795
* Ranked among companies with meaningful Gross Margin % only.

QUIA PHARMA AB had a gross margin of % for the quarter that ended in Jun. 2025 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for QUIA PHARMA AB was 0.00% per year.

QUIA PHARMA AB (FRA:99B0) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

QUIA PHARMA AB had a gross margin of % for the quarter that ended in Jun. 2025 => No sustainable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

QUIA PHARMA AB Gross Margin % Related Terms

QUIA PHARMA AB Gross Margin % Historical Data

* Premium members only.

The historical data trend for QUIA PHARMA AB's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

QUIA PHARMA AB Gross Margin % Chart

QUIA PHARMA AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Gross Margin %

Get a 7-Day Free Trial

-160.66

0.00

QUIA PHARMA AB Semi-Annual Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25
Gross Margin %	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

FRA:99B0 vs VRTX, REGN, ALNY: Gross Margin % Comparison

For the Biotechnology subindustry, QUIA PHARMA AB's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

QUIA PHARMA AB Gross Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, QUIA PHARMA AB's Gross Margin % distribution charts can be found below:

* The bar in red indicates where QUIA PHARMA AB's Gross Margin % falls into.

Save Embed

QUIA PHARMA AB Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

QUIA PHARMA AB's Gross Margin for the fiscal year that ended in Dec. 2024 is calculated as

Gross Margin % (A: Dec. 2024 )	=	Gross Profit (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	0	/	0
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(0 - -0.029)	/	0
	=	%

QUIA PHARMA AB's Gross Margin for the quarter that ended in Jun. 2025 is calculated as

Gross Margin % (Q: Jun. 2025 )	=	Gross Profit (Q: Jun. 2025 )	/	Revenue (Q: Jun. 2025 )
	=	-0	/	0
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(0 - 0.022)	/	0
	=	%

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Frequently Asked Questions Learn more about Gross Margin % →

What does a Gross Margin % of 0.00% mean?

QUIA PHARMA AB (FRA:99B0) has a Gross Margin % of 0.00% as of Jun. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on QUIA PHARMA AB and its competitors.

Is QUIA PHARMA AB's Gross Margin % too high?

QUIA PHARMA AB's current Gross Margin % is 0.00%.

How does QUIA PHARMA AB's Gross Margin % compare to VRTX and REGN?

QUIA PHARMA AB's Gross Margin % of 0.00% can be compared against companies in the Biotechnology industry. The industry median Gross Margin % is 60.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Gross Margin % for a Biotechnology company?

The median Gross Margin % among Biotechnology companies is 60.80, based on 734 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Gross Margin % mean?

A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on QUIA PHARMA AB and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. QUIA PHARMA AB's current Gross Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is QUIA PHARMA AB stock overvalued right now?

QUIA PHARMA AB (FRA:99B0) has a current Gross Margin % of 0.00%. The current Gross Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Gross Margin % calculated?

Gross Margin % is calculated from a company's financial statements. For QUIA PHARMA AB (FRA:99B0), the current Gross Margin % is 0.00% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

QUIA PHARMA AB Business Description

Industry Healthcare Biotechnology

Comparable Companies OSTO:LIDDS OSTO:LPGO VRTX REGN ASX:CSL XKRX:207940 ALNY XBRU:UCB XBRU:ARGX INSM ONC XKRX:068270 BNTX OCSE:GMAB INCY HKSE:01801 HKSE:02269 RPRX XKRX:196170 RVMD

Address Virdings Alle 32 B, Uppsala, SWE, 754 50

Website https://www.quiapeg.com

QUIA PHARMA AB is a development company for pharmaceuticals based on a patented drug delivery platform, Uni-Qleaver. The company develops improved and patentable forms of drugs under development or already approved by pharmaceutical authorities. These refined and enhanced forms of medicine are based on the Company's exceptional and patented technology platform. In addition to this, the Company offers multinational sales of omega-3, astaxin and collagen through Amazon.